Cardiometabolic Dysfunction

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-05-27
Clinical Trial Update: PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction [Phase 2]
Phase 2 trial investigating PDE5 inhibition for obesity-related cardiometabolic dysfunction has completed with posted results.